Veeva Systems Reveals Results of Field Medical Engagement Impact Study
Research concludes professional disease education leads to greater treatment adoptions.
Through its Veeva Pulse Field Trends Report, Veeva Systems has announced the findings of field medical's impact on clinical practice. According to the report’s analysis, disease state education by medical science liaisons (MSLs) with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption.
Reportedly, scientific engagement with KOLs provides an enduring impact on new treatment adoption. Despite this discovery, 70% only engage with one company's field medical team, leaving a need for better field planning and connected insights across organizations.
"The right data is foundational to our engagement strategy. We can quickly identify who the relevant KOLs are and organize those KOLs based on when and where they are sharing scientific information and what scientific information they are sharing," said Christine Castro, director of medical affairs excellence, Lundbeck, in a company press release. "As we prepared for the launch of new treatments, this data-driven approach helped us build the right relationships and focus our resources where they will have the greatest scientific impact."
Reference: Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment Adoption. PR Newswire. July 26, 2023. Accessed July 28, 2023. https://www.prnewswire.com/news-releases/veeva-pulse-uncovers-field-medical-engagement-drives-1-5x-increase-in-treatment-adoption-301885869.html
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
